QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights

被引:2
作者
Lopez-Medina, Ana I. [1 ]
Campos-Staffico, Alessandra M. [1 ]
Luzum, Jasmine A. [1 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Clin Pharm, 428 Church St, Ann Arbor, MI 48109 USA
关键词
arrhythmia; azithromycin; COVID-19; hydroxychloroquine; ion channels; pharmacogenetics; polymorphism; QT prolongation;
D O I
10.1111/jce.14722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2793 / 2794
页数:2
相关论文
共 50 条
[21]   HYDROXYCHLOROQUINE AND AZITHROMYCIN COMBINATION COULD BE LETHAL TO COVID-19 PATIENTS [J].
Mohammad, Firdous Sayeed ;
Karmakar, Varnita ;
Irfan, Zainab .
FARMACIA, 2020, 68 (03) :384-389
[22]   Evaluation of Corrected QT Intervals of 74 COVID-19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir [J].
Uyaroglu, Oguz Abdullah ;
Sener, Yusuf Ziya ;
Ozdede, Murat ;
Basaran, Nursel Calik ;
Ozisik, Lale ;
Sahin, Taha Koray ;
Canpolat, Ugur ;
Inkaya, Ahmet Cagkan ;
Yorgun, Hikmet ;
Guven, Gulay Sain ;
Aytemir, Kudret .
EUROPEAN JOURNAL OF THERAPEUTICS, 2021, 27 (04) :311-317
[23]   Hydroxychloroquine/azithromycin in COVID-19: The association between time to treatment and case fatality rate [J].
Alfonso Accinelli, Roberto ;
Jesus Ynga-Melendez, Grisel ;
Alonso Leon-Abarca, Juan ;
Marianella Lopez, Lidia ;
Carlos Madrid-Cisneros, Juan ;
Diego Mendoza-Saldana, Juan .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 44
[24]   Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine [J].
Sarayani, Amir ;
Cicali, Brian ;
Henriksen, Carl H. ;
Brown, Joshua D. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (02) :483-486
[25]   Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19 [J].
Albani, Filippo ;
Fusina, Federica ;
Giovannini, Alessia ;
Ferretti, Pierluigi ;
Granato, Anna ;
Prezioso, Chiara ;
Divizia, Danilo ;
Sabaini, Alessandra ;
Marri, Marco ;
Malpetti, Elena ;
Natalini, Giuseppe .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) :1-10
[26]   Azithromycin in the treatment of COVID-19: a review [J].
Echeverria-Esnal, Daniel ;
Martin-Ontiyuelo, Clara ;
Navarrete-Rouco, Maria Eugenia ;
De-Antonio Cusco, Marta ;
Ferrandez, Olivia ;
Horcajada, Juan Pablo ;
Grau, Santiago .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (02) :147-163
[27]   Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine [J].
Bakadia, Bianza Moise ;
He, Feng ;
Souho, Tiatou ;
Lamboni, Lallepak ;
Ullah, Muhammad Wajid ;
Boni, Biaou Ode ;
Ahmed, Abeer Ahmed Qaed ;
Mukole, Biampata Mutu ;
Yang, Guang .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
[28]   QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment [J].
Grewal, Sarah ;
Jankelson, Lior ;
van den Broek, Marcel P. H. ;
Cour, Martin ;
Bachmann, Gloria ;
Kostis, John B. ;
Misra, Kamana .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
[29]   Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes? [J].
Megarbane, Bruno ;
Scherrmann, Jean-Michel .
JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (07) :808-814
[30]   Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin Treatment [J].
Ng, Kenneth K. ;
Ng, Mitchell K. ;
Zhyvotovska, Angelina ;
Singh, Sahib ;
Shevde, Ketan .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)